ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Eris Lifesciences has filed a notification informing exchanges that the transcript of its analyst and investor conference call — held after the announcement of Q4 and full-year FY26 results ending March 31, 2026 — is now publicly available on the company's website. The filing is dated May 26, 2026, and is signed by the Company Secretary. No financial figures or discussion content are included in this disclosure itself.
This filing is a routine regulatory disclosure confirming the availability of earnings call transcripts to retail investors. It does not directly signal any immediate price impact but confirms transparency in communication post-quarterly results.